Sanofi SA

04/28/2021 | Press release | Distributed by Public on 04/27/2021 23:35

Chiffre d’affaires par GBU, franchise, région et produit – T1 2021

Feuil1

TRIMESTRE 1
T1 2021 (en million d'euros) Total chiffre d'affaires Var. TCC Var. Publiée Etats-Unis Var. TCC Europe Var. TCC Reste du monde Var. TCC
Dupixent 1,047 45.6% 34.9% 793 41.6% 137 52.2% 117 71.2%
Aubagio 500 -1.1% -7.6% 339 -5.1% 132 12.7% 29 -3.1%
Lemtrada 24 -44.9% -51.0% 10 -52.2% 5 -61.5% 9 -15.4%
Kevzara 57 10.9% 3.6% 25 -15.6% 21 5.0% 11 333.3%
Neurologie & Immunologie 581 -3.4% -9.9% 374 -8.3% 158 5.3% 49 14.6%
Cerezyme 178 4.2% -5.8% 40 -6.5% 63 -4.5% 75 18.4%
Cerdelga 62 13.8% 6.9% 32 12.9% 26 8.3% 4 66.7%
Myozyme 235 0.8% -4.5% 88 11.5% 98 -4.8% 49 -5.5%
Fabrazyme 208 4.7% -2.8% 93 -2.9% 57 9.6% 58 13.8%
Aldurazyme 66 7.5% -1.5% 12 8.3% 23 9.5% 31 5.9%
Total maladies rares 770 4.4% -3.0% 265 3.2% 267 0.4% 238 10.2%
Jevtana 126 -2.9% -8.7% 58 5.0% 45 -11.8% 23 -3.7%
Fasturtec 35 8.6% 0.0% 21 4.5% 11 10.0% 3 33.3%
Libtayo 26 125.0% 116.7% - - 22 120.0% 4 150.0%
Sarclisa 34 3400.0% 3300.0% 12 1200.0% 13 - 9 -
Total Oncologie 221 25.8% 18.8% 91 19.3% 91 28.2% 39 37.5%
Alprolix 100 -1.8% -8.3% 79 3.6% - - 21 -19.2%
Eloctate 134 -9.9% -16.8% 103 -5.0% - - 31 -23.8%
Cablivi 38 66.7% 58.3% 22 60.0% 15 66.7% 1 -
Total maladies hématologiques rares 272 -0.7% -7.5% 204 2.8% 15 66.7% 53 -20.6%
Médecine de spécialités 2,891 15.3% 7.3% 1,727 15.2% 668 13.9% 496 17.6%
Lantus 652 -3.7% -9.9% 192 -8.7% 125 -16.1% 335 4.9%
Toujeo 253 5.1% -1.6% 62 0.0% 94 -5.0% 97 20.2%
Soliqua/iGlarLixi 44 29.7% 18.9% 26 27.3% 7 16.7% 11 44.4%
Autres diabète 226 -7.3% -13.7% 44 -11.1% 64 -7.1% 118 -5.8%
Total diabète 1,175 -1.7% -8.2% 324 -5.3% 290 -10.2% 561 5.3%
Lovenox 401 30.4% 21.9% 13 75.0% 186 10.5% 202 50.7%
Plavix 251 -4.0% -8.1% 2 - 29 -23.7% 220 -2.1%
Multaq 72 -3.7% -11.1% 62 -4.2% 6 0.0% 4 0.0%
Praluent 56 -20.5% -23.3% 5 -81.3% 36 20.0% 15 45.5%
Aprovel 101 -39.7% -42.0% 2 -60.0% 23 -23.3% 76 -42.4%
Mozobil 52 1.9% -3.7% 28 -6.3% 14 0.0% 10 37.5%
Thymoglobulin 80 1.2% -5.9% 46 0.0% 8 -11.1% 26 8.0%
Génériques 206 3.5% -10.8% 29 -13.5% 2 0.0% 175 6.8%
Autres produits prescrits 1,090 -12.2% -16.7% 76 -31.4% 349 -21.6% 665 -3.3%
Total Cardiovasculaire & Produits de prescription établis 2,309 -5.6% -11.5% 263 -19.0% 653 -12.0% 1,393 0.7%
Ventes Industrielles 188 8.8% 3.9% 11 9.1% 156 9.0% 21 8.0%
Médecine Générale 3,672 -3.8% -9.8% 598 -11.7% 1,099 -9.0% 1,975 2.1%
Total Pharma 6,563 3.8% -3.0% 2,325 6.8% 1,767 -1.5% 2,471 4.9%
Vaccins Polio / Petussis / HIB 533 14.9% 10.1% 135 40.4% 78 6.8% 320 8.2%
Vaccins Rappel adultes 100 -8.7% -13.0% 48 -3.7% 34 -26.1% 18 26.7%
Vaccins Méningite / Pneumonie 128 3.8% -2.3% 76 3.8% - - 52 3.9%
Vaccins contre la grippe 77 23.8% 22.2% - -100.0% 9 300.0% 68 45.8%
Vaccins pour voyageurs et autres vaccins endémiques 59 -37.4% -40.4% 14 -37.5% 5 -83.9% 40 -4.5%
Vaccins 915 5.3% 0.7% 285 7.6% 127 -16.3% 503 10.9%
Allergie 195 -6.2% -13.3% 106 3.6% 18 0.0% 71 -18.9%
Toux, rhume et grippe 55 -59.4% -61.5% - - 25 -67.5% 30 -50.0%
Douleur 253 -11.6% -18.6% 40 -13.7% 122 -14.5% 91 -7.0%
Santé Digestive 283 14.6% 5.6% 25 22.7% 105 0.0% 153 24.5%
Bien-être physique 81 2.3% -5.8% - - 8 14.3% 73 1.3%
Bien-être mental 53 18.8% 10.4% 11 9.1% 29 15.4% 13 36.4%
Hygiène personnelle 125 2.2% -6.7% 96 1.9% 1 0.0% 28 3.3%
Autres 68 -15.3% -20.0% 5 66.7% 26 -33.3% 37 -4.7%
Santé Grand Public 1,113 -7.3% -14.4% 283 2.3% 334 -19.3% 496 -3.6%
Total Sanofi 8,591 2.4% -4.3% 2,893 6.4% 2,228 -5.6% 3,470 4.3%